Private Asset Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Private Asset Management’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,000	Closed	-$1.15M	–	141
2017 Q4	$1.15M	Hold	34,000	–	–	0.18%	73
2017 Q3	$720K	Hold	34,000	–	–	0.12%	86
2017 Q2	$595K	Hold	34,000	–	–	0.1%	93
2017 Q1	$595K	Sell	34,000 -5,000	-13%	-$85.2K	0.1%	94
2016 Q4	$659K	Hold	39,000	–	–	0.11%	85
2016 Q3	$640K	Hold	39,000	–	–	0.11%	93
2016 Q2	$590K	Hold	39,000	–	–	0.1%	94
2016 Q1	$564K	Sell	39,000 -2,000	-5%	-$33.7K	0.1%	92
2015 Q4	$1.16M	Hold	41,000	–	–	0.21%	73
2015 Q3	$686K	Sell	41,000 -6,690	-14%	-$152K	0.13%	87
2015 Q2	$1.25M	Hold	47,690	–	–	0.21%	71
2015 Q1	$834K	Hold	47,690	–	–	0.14%	83
2014 Q4	$828K	Buy	+47,690	New	+$724K	0.13%	84

Other funds holding ADMS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BWCA

Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Private Asset Management's ADMS Position: Q1 2018 in Review

Private Asset Management sold out of Adamas Pharmaceuticals (ADMS) in Q1 2018, closing a stake of 34,000 shares — an estimated $1.15M sold.

Private Asset Management first reported a position in ADMS in Q4 2014 and held it in 13 quarters. The position peaked at $1.25M in Q2 2015. 118 funds tracked by Wall St. Rank hold ADMS as of Q1 2018.

Private Asset Management reported no remaining Adamas Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Private Asset Management sold 34,000 Adamas Pharmaceuticals shares in Q1 2018, an estimated $1.15M.
Private Asset Management first reported a position in Adamas Pharmaceuticals in Q4 2014 and held it in 13 quarters.
Private Asset Management's Adamas Pharmaceuticals position peaked at $1.25M in Q2 2015.
118 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2018.

Based on Private Asset Management's 13F filing for Q1 2018, filed 6 Apr 2018.